These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21744352)

  • 1. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
    Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
    Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
    Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
    Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma.
    Oue N; Noguchi T; Anami K; Kitano S; Sakamoto N; Sentani K; Uraoka N; Aoyagi K; Yoshida T; Sasaki H; Yasui W
    Ann Surg Oncol; 2012 Jun; 19(6):1902-10. PubMed ID: 22203179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
    Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
    Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
    J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
    Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW
    Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
    Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
    Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
    Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
    Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
    Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
    Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
    Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
    J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
    Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
    Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.
    Li K; Wang RW; Jiang YG; Zou YB; Guo W
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.